Calidi Biotherapeutics, Inc. Common Stock CLDI 深 滬
已收盤 09-20 16:00:00 美东时间
1.09
-0.015
-1.36%
華盛通- 最 高1.1399
- 今 開1.11
- 成交量 6.78万股
- 最 低 1.08
- 昨 收 1.105
- 總市值 699.68万
- 52周最高 38.00
- 市盈率 靜 --
- 換手率 1.06%
- 52周最低 1.01
- 委 比 0.00%
- 總股本 641.91万
- 歷史最高 240.50
- 量 比 1.26
- 振 幅 5.42%
- 歷史最低 1.08
- 每 手 1
- 風險率 9.89%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Calidi Biotherapeutics Unveils Redtail Biopharma Subsidiary
Calidi Biotherapeutics (CLDI) has provided an announcement. Calidi Biotherapeut...
08-23 05:49
Calidi Biotherapeutics GAAP EPS of -$1.40
Calidi Biotherapeutics press release (NYSE:CLDI): Q2 GAAP EPS of -$1.40. The company had approximately $0.8 million in cash and $0.2 million in restricted cash as of June 30, 2024, compared to $1.9 mi...
08-15 00:28
Calidi Biotherapeutics Q2 2024 GAAP EPS $(1.40) Beats $(1.45) Estimate
Calidi Biotherapeutics (AMEX:CLDI) reported quarterly losses of $(1.40) per share which beat the analyst consensus estimate of $(1.45) by 3.45 percent.
08-14 05:39
Calidi Biotherapeutics Secures Investment, Expands Advisory Board
Calidi Biotherapeutics (CLDI) has issued an update. Calidi Biotherapeutics, Inc...
07-29 21:48
Calidi Biotherapeutics Has Been Granted U.S. Patent Number 12,036,278 Titled "Smallpox Vaccine For Cancer Treatment".
https://ppubs.uspto.gov/pubwebapp/external.html?q=(12036278).pn
07-16 23:19
Calidi Biotherapeutics Announces 1-for-10 Reverse Stock Split
Calidi Biotherapeutics (CLDI) has shared an announcement. The Company has annou...
07-06 04:58
Calidi Biotherapeutics to effect 1-for-10 reverse stock split
Biotechnology company Calidi Biotherapeutics (NYSE:CLDI) said on Friday that it is set to effect a 1-for-10 reverse stock split, effective 12:01 AM ET on July 15. CLDI shares were trading -1.83% post-...
07-06 04:23
Calidi Biotherapeutics Welcomes Dr. George Peoples to Board
Calidi Biotherapeutics (CLDI) just unveiled an announcement. Calidi Biotherapeu...
06-27 04:48
Why Oracle Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Shares of Oracle Corporation (NYSE:ORCL) rose sharply in today's pre-market tra...
06-12 17:33
Why Calidi Biotherapeutics is Moving Higher Monday
Calidi and SIGA are partnering in order to advance Calidi's RTNova virotherapy for lung cancer and metastatic solid tumors.
06-10 22:53
